Double Trouble for Cancer Tumors: The Dual-Action Immunotherapy Breakthrough

The small molecule, now in clinical trials, increases activity of immune cells and sensitivity of tumors to immune attack. Cancer immunotherapy drugs called PD-1 inhibitors…

Leave a Reply

Your email address will not be published. Required fields are marked *

Game Development